TSB 9 W1Alternative Names: IDS; TSB-9-W1
Latest Information Update: 22 Feb 2016
At a glance
- Originator Taiwan Sunpan Biotechnology Development
- Class Antineoplastics
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Colorectal cancer
Most Recent Events
- 04 Sep 2014 Investigation in Colorectal cancer (Second-line therapy or greater, Late-stage disease) in Taiwan (PO)